PNEUMOVAX 23 Solución inyectable en vial Vacuna antineumocócica de polisacáridos
Sponsors
Apellis Pharmaceuticals Inc., Novartis Pharma AG
Conditions
C3 glomerulopathy (C3G) or immune complex membranoproliferative glomerulonephritis (IC-MPGN)Relapsing multiple sclerosis (RMS)
Phase 3
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis (VALE)
Active, not recruitingCTIS2023-504625-39-00
Start: 2023-05-18Target: 66Updated: 2026-01-08
An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis (RMS)
Active, not recruitingCTIS2023-507906-15-00
Start: 2019-01-30Target: 963Updated: 2025-11-14